Ember Therapeutics Company Profile
Ember Therapeutics is a product-focused company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease. Today’s rising epidemic of obesity and Type 2 diabetes coupled with the lack of innovation in the industry’s metabolic disorder treatment pipeline underscores the need for novel, peripherally-acting treatments with improved safety profiles. Ember’s unique approach leverages recent research breakthroughs in brown fat biology to develop a pipeline of proprietary large and small molecules designed to amplify the body’s innate ability to efficiently burn fuels like glucose. Ember’s expertise is also driving the development of the next generation of highly selective insulin sensitizers that have robust anti-diabetic effects, but lack the serious side effects of currently approved insulin sensitizers. Formerly known as Adipothermics, Ember Therapeutics is a private company launched in 2011 by renowned scientific founders, an experienced leadership team and Third Rock Ventures. For more information, please visit www.embertx.com.
News Articles
Ember receives options for brown fat IP
Ember Therapeutics Inc. (Boston, Mass.) received exclusive options to IP for three targets related to its brown fat small molecule drug discovery program. Brigham and Women's Hospital gave the company...
Ember: warming up to brown fat
Boston-area researchers have shown that inhibiting a cation channel dubbed TRPV4 induced white fat cells to behave like brown fat, thereby protecting mice from diet-induced obesity and insulin resista...
New supercomputer to aid genomics research
(Institute for Genomic Biology, University of Illinois at Urbana-Champaign) The National Center for Supercomputing Applications has gifted the Institute for Genomic Biology a highly parallel shared me...
Ember Therapeutics management update
[Ember] strikes alliance with [Brigham & Women's Hospital]
In its third deal with a tech transfer entity this year, metabolic disease-focused start-up [Ember Therapeutics Inc.] has received an exclusive option from [Brigham and Women’s Hospital] to two smal...
Ember Therapeutics, Brigham and Women's Hospital, Dana-Farber Cancer Institute deal
Ember Therapeutics, Inc., a company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease, today annou...
Ember Therapeutics Expands Scientific Leadership to Advance Metabolic Pipeline
Ember Therapeutics, Inc., a company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease, today annou...
Drugs and Medications
None
PubMed Articles
Multi-domain GFP-like proteins from two species of marine hydrozoans.
Proteins homologous to Green Fluorescent Protein (GFP) are widely used as genetically encoded fluorescent labels. Many developments of this technology were spurred by discoveries of novel types of GFP...
BACKGROUND: Total knee arthroplasty (TKA) is a procedure with associated risks of inadvertent perioperative hypothermia and significant postoperative pain. Hypothermia may affect patients' experience...
Clinical Trials
None
Companies
Ember Therapeutics is a product-focused company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease. TodayÃ...
Ember Therapeutics is a product-focused company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease. TodayÃ...
More Information about "Ember Therapeutics" on BioPortfolio
We have published hundreds of Ember Therapeutics news stories on BioPortfolio along with dozens of Ember Therapeutics Clinical Trials and PubMed Articles about Ember Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ember Therapeutics Companies in our database. You can also find out about relevant Ember Therapeutics Drugs and Medications on this site too.
